ArticleFuture oncology (London, England)2021

EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma.

Edith Julia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.